Organon & Co (NYSE:OGN)
$ 15.06 0.11 (0.74%) Market Cap: 3.85 Bil Enterprise Value: 11.78 Bil PE Ratio: 2.97 PB Ratio: 7.81 GF Score: 71/100

Q4 2023 Organon & Co Earnings Call Transcript

Feb 15, 2024 / 01:30PM GMT
Release Date Price: $18.62 (+13.81%)
Operator

Thank you for standing by, and welcome to the Organon Q4 Full Year 2023 Earnings Call and Webcast. I would now like to welcome Jennifer Halchak, Vice President of Investor Relations to begin the call. Jennifer, over to you.

Jennifer Halchak
Organon & Co. - VP of IR

Thank you, operator. Good morning, everyone. Thank you for joining Organon's Fourth Quarter 2023 and Full Year 2023 Earnings Call. With me today are Kevin Ali, Organon's Chief Executive Officer, who will cover strategy and operational highlights; and Matt Walsh, our Chief Financial Officer, who will review performance and guidance. Also joining us for the Q&A portion of this call is Organon's new Head of R&D; Juan Camilo Arjona Ferreira.

Today, we will be referencing a presentation that will be visible during this call for those of you on our webcast. The presentation will also be available following this call on the Events and Presentations section of our Organon Investor Relations website at www.organon.com.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot